Treatment Registry

Company

Heva Health

Heva Health publishes compounded tirzepatide at $339 a month — Tirzepatide, any dose, month-to-month.

  • 1 program
  • 1 molecule
  • 1 reading

Read from hevahealth.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to Heva Health

Visit Heva Health

We earn nothing from this link. Heva Health has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

first month, including the required fees on record · Tirzepatide, any dose, month-to-month

Terms

Not yet checked: pharmacy, membership, consultation fee and states.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderPer month
at its shortest term
Link
TR-0141Heva Health$339
Tirzepatide, any dose, month-to-month
Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. The /weight-loss page's nav toggles between a 'Semaglutide' and 'Tirzepatide' tab, but only the Tirzepatide tab's content and price rendered in static HTML (the page loaded as 'Home / Weight Loss / Tirzepatide'); /weight-loss/semaglutide 404'd, so no semaglutide price could be recorded despite the drug clearly being offered in the same UI. Separately, Heva's other (non-GLP-1) 'Full-Service Care' track is listed as available only in AZ, CO, CT, FL, IA, ID, NV, NY, UT, VA, WA, WY, while the GLP-1 'Direct Access' track is 'Available nationwide' — the AK/AR/IN/MN/SC exclusion above is the only concrete state restriction found specific to Tirzepatide itself.

Before you act

Cite this

Treatment Registry. (2026). Heva Health: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/heva-health